Answers are grounded in this paper and cite their sources.
Onychomycosis in children is uncommon. In those children that are affected, a family history of onychomycosis is not uncommon, giving importance to the examination of the entire family for fungal nail infections. In the United States, the newer oral antifungal agents itraconazole, fluconazole, and terbinafine, and the topical nail lacquers ciclopirox and amorolfine are not approved for this indication. More data are needed on the use of these antifungal agents for the treatment of onychomycosis in children.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: